Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A tumour-resident Lgr5+stem-cell-like pool drives the establishment and progression of advanced gastric cancers

Autor: Fatehullah, A., Terakado, Y., Sagiraju, S., Tan, T. L., Sheng, T., Tan, S. H., Murakami, K., Swathi, Y., Ang, N., Rajarethinam, R., Ming, T., Tan, P., Lee, B., Barker, N.

Publikováno v: Nature Cell Biology; December 2021, Vol. 23 Issue: 12 p1299-1313, 15p

Development and Validation of a Comprehensive Prognostic and Depression Risk Index for Gastric Adenocarcinoma.

Autor: Tian, Sheng^1,2,3 (AUTHOR) 2016302180097@whu.edu.cn, Liu, Yixin^1,2,3 (AUTHOR) yixinliu@whu.edu.cn, Liu, Pan^1,2,3 (AUTHOR) liupanzn@whu.edu.cn, Nomura, Sachiyo⁴ (AUTHOR) sachiyo.nomura1012@gmail.com, Wei, Yongchang^1,2,3 (AUTHOR) weiyongchang@whu.edu.cn, Huang, Tianhe^1,2,3 (AUTHOR) weiyongchang@whu.edu.cn

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10776. 19p.

Targeting p53 in chronic lymphocytic leukemia.

Autor: Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Boggione P; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Mahmoud AM; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Kodipad AA; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Adhinaveni R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Sagiraju S; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Patriarca A; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale , Novara, Italy.

Publikováno v: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2020 Dec; Vol. 24 (12), pp. 1239-1250. Date of Electronic Publication: 2020 Oct 19.

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.

Autor: Diop F; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Moia R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Favini C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Spaccarotella E; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., De Paoli L; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Bruscaggin A; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Spina V; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Terzi-di-Bergamo L; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Arruga F; Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy., Tarantelli C; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland., Deambrogi C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Rasi S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Adhinaveni R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Patriarca A; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Favini S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Sagiraju S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Jabangwe C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Kodipad AA; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Peroni D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy., Mauro FR; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Giudice ID; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Forconi F; Cancer Sciences Unit, Southampton Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Division of Hematology, University of Siena, Siena, Italy., Cortelezzi A; Department of Hematology Oncology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy., Zaja F; Clinica Ematologica, DAME, University of Udine, Udine, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy., Rossi FM; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy., Visco C; Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy., Chiarenza A; Division of Hematology, Azienda Ospedaliera Universitaria Policlinico-OVE, Catania, Italy., Rigolin GM; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy., Marasca R; Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy., Coscia M; Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza and University of Turin, Turin, Italy., Perbellini O; Section of Hematology, Department of Medicine, University of Verona, Verona, Italy., Tedeschi A; Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy., Laurenti L; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy., Motta M; Department of Hematology, Spedali Civili, Brescia, Italy., Donaldson D; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK., Weir P; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK., Mills K; Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, Northern Ireland, UK., Thornton P; Department of Haematology, Beaumont Hospital, Dublin, Ireland., Lawless S; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK., Bertoni F; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland., Poeta GD; Department of Hematology, Tor Vergata University, Rome, Italy., Cuneo A; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy., Follenzi A; Department of Health Sciences, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy., Boldorini RL; Department of Pathology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy., Catherwood M; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK., Deaglio S; Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy., Foà R; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy gianluca.gaidano@med.uniupo.it., Rossi D; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland davide.rossi@eoc.ch.

Publikováno v: Haematologica [Haematologica] 2020 Jan 31; Vol. 105 (2), pp. 448-456. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).